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Reliable data on familial risks are important for clinical counselling and cancer genetics. However, the estimates of familial risk of gastric
cancer vary widely. We examined the risk of familial gastric cancer using the updated Swedish Family-Cancer Database with 5358
patients among offspring and 36486 patients among parents. There were 133 families with one parent and one offspring diagnosed
with gastric cancer, and 20 families with two affected offspring. Familial standardised incidence ratios (SIRs) were 1.63 and 2.93 when
parents and siblings presented with gastric cancer, respectively. The high sibling risk was owing to cancer in the corpus (SIR 7.28). The
SIR for cardia cancer was 1.54 when parents were diagnosed with any gastric cancer. Cardia cancer associated with oesophageal
cancer, particularly with oesophageal adenocarcinoma. Among specific histologies, signet ring cancer showed an increase. A few
associations were noted for discordant sites, including the urinary bladder and the endometrium. H. pylori infection, although not
measured in the present study, is probably an important risk factor for the high sibling risk of corpus cancer. Familial clustering of
cardia cancer is independent of H. pylori infection, and may have a genetic basis. The familial association of cardia cancer with
oesophageal adenocarcinoma may provide aetiological clues.
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Although the incidence of gastric cancer has declined in the past
several decades, it remains the second most common cause of
cancer-related deaths in the world (Parkin et al, 2001). It has been
estimated that there were more than 870000 deaths from this
disease in the year 2000 (Pisani et al, 1993). In Sweden, gastric
cancer amounts to 2.3% of all malignancies (Center for Epidemio-
logy, 2002). Approximately 90% of gastric cancers are adenocarci-
nomas, whereas leiomyosarcomas, carcinoids and undifferentiated
tumours are rare, making up most of the remaining 10%. According
to the Lauren classification, adenocarcinomas can be subdivided
into two histological types, the intestinal type, with a greatly
declined incidence rate, and the diffuse type, exhibiting a relatively
constant rate. Most gastric carcinomas are located distal to the
cardia (corpus cancer), which has markedly declined in the Western
countries, including Sweden; about 25% are localised proximally
in the cardia (cardia cancer), with a relatively stable incidence
(Desoubeaux et al, 1999; Ekstrom et al, 1999; Ekstrom et al, 2000).
Helicobacter pylori is a main risk factor of distal gastric cancer
(Huang et al, 1998; Crew and Neugut, 2004). The infection causes
a chronic active inflammation in the gastric mucosa and, in a
subgroup, gastritis arises in the corpus, which is a risk factor for
gastric cancer (Uemura et al, 2001). Other risk factors of distal
gastric cancer include dietary nitrite, salt, and smoking (Hirohata
and Kono, 1997; Ye et al, 1999; Kobayashi et al, 2002; Ngoan and
Yoshimura, 2003; Crew and Neugut, 2004). As for cardia cancer,
H. pylori infection appears not to be important and there may even
be an inverse association (Crew and Neugut, 2004; Ye et al, 2004).
Smoking, dietary nitrite and obesity may be risk factors of cardia
cancer (Lagergren et al, 1999b; Ye et al, 1999; Crew and Neugut,
2004). A positive family history is a risk of gastric cancer but the
reported risks ranged widely from about 1.3 to 3.0 (La Vecchia
et al, 1992; Munoz et al, 1997; Lissowska et al, 1999; Lagergren
et al, 2000; Hemminki and Jiang, 2002b; Amundadottir et al, 2004;
Kerber and O’Brien, 2005). Gastric cancer is a manifestation of
several cancer syndromes, such as hereditary nonpolyposis colo-
rectal carcinoma (HNPCC, particularly in Japanese families),
adenomatous polyposis (FAP) and some other rare syndromes
(Lynch and de la Chapelle, 2003).
In view of the varying familial risk estimates for gastric cancer, we
examined here the risk using the newest update of the nation-wide
Swedish Family-Cancer Database, which covered offspring between
birth and age 72 years and their parents. Compared with the earlier
study from this Database based on 58 familial cases in the first-degree
relatives (Hemminki and Jiang, 2002b), the extended population
included 153 familial gastric cancers, allowing a more exact definition
of the familial risk and analysis by specific histological types and
anatomical sites. A familial risk of cardia cancer, if demonstrated,
would be independent of infection by H. pylori (Ye et al, 2004).
Besides, the associations of gastric cancer with other tumours in
families were also examined. The special properties of the Database
include registered sources of family relationships and medically
verified cancer cases with practically complete national coverage. This
is the largest study published on familial gastric cancer.
MATERIALS AND METHODS
Statistics Sweden maintains a ‘Multigeneration Register’ where
children, offspring, born in Sweden in 1932 and later are registered
with their biological parents and they are organised as families
(Hemminki et al, 2001a). The latest version of the Multigeneration
Register, which has been incorporated in the Database, includes
supplementary data from church records on index persons
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sdomiciled in Sweden between 1947 and 1961, including informa-
tion about biological parents, children, siblings, and adoptions.
This Register was linked by the individually unique national
registration number to the Cancer Registry to create the Swedish
Family-Cancer Database (MigMed2), which was updated in 2006
with cancer cases from 1958 to 2004. The data on families and
cancers have a complete coverage, barring some groups of
deceased offspring, which affected those born in the 1930s and
those who died before 1991. Although this small group of offspring
with missing links to parents has a negligible effect on the estimate
of familial risk (Dong and Hemminki, 2001), we limited the present
study to offspring whose parents were known to eliminate the
possibility of bias. Cancer registration is currently considered to
be close to 100% (Center for Epidemiology, 2002). A four-digit
diagnosis code according to the 7th revision of the International
Classification of Diseases (ICD-7) has been used. The following
ICD-7 codes were grouped: ‘upper aero digestive tract’ cancer
codes 161 (larynx) and 140–148 (lip, mouth, and pharynx), except
for code 142 (salivary glands), ‘non-Hodgkin lymphoma’ codes 200
and 202, and ‘leukaemia’ codes 204–207 (leukaemia), 208
(polycytemia vera) and 209 (myelofibrosis). Rectal cancer, ICD-7
code 154, was subdivided into the anus (squamous cell carcinoma,
154.1) and mucosal rectum (154.0). Basal cell carcinoma of the
skin is not registered in the Cancer Registry. Lymphomas are
classified as independent entities irrespective of their anatomic
sites. Only the first gastric cancer was considered in the present
study, and a total of 5358 offspring and 36486 parents were
diagnosed with gastric cancer in the Database. Most Swedish
counties recorded gastric cancer with histopathological data by
the Systematised Nomenclature of Medicine (SNOMED, http://
snomed.org) from year 1990, but the nation-wide application of
SNOMED code was available after 1993. To avoid loss of cases, we
included those cases diagnosed between years 1990 and 2004 for
the analysis of familial risks by histology.
Family history of gastric cancer was determined for each
offspring in the beginning of the follow-up period. Gastric cancer
incidence was compared among offspring with or without family
history. If not specified otherwise, the follow-up was started for each
offspring at birth, immigration or on 1 January 1961, whichever was
the latest time. Follow-up was terminated at the diagnosis of first
cancer, death, emigration or the closing date of the study on 31,
December 2004. Standardised incidence ratios (SIRs) were used to
measure the cancer risks for offspring according to the occurrence
of cancers in their families. SIRs were calculated and results are
shown for offspring gastric cancer when the parent, sibling or parent
and sibling had any cancer, that is using parents, siblings or parents
and siblings as probands in mutually exclusive categories. When
more than two affected offspring were found in any family, they
were counted as independent events.
Parents’ ages were not limited, but offspring were 0–72 years of
age. SIRs were calculated as the ratio of observed (O) to expected
(E) number of cases. The expected numbers were calculated from
5-year-age, gender, tumour type, period, socioeconomic status (six
groups), and residential area (three groups) specific standard
incidence rates for all offspring lacking a family history (Esteve
et al, 1994). Confidence intervals (95 and 99% CI) were calculated
assuming a Poisson distribution, and they were rounded to the
nearest two decimals (Esteve et al, 1994). Risks for siblings were
calculated using the cohort method, as described elsewhere
(Hemminki et al, 2001b).
RESULTS
Familial gastric cancer
The Swedish Family-Cancer Database, which covered years 1961–
2004 from the Swedish Cancer Registry, included 5358 offspring
(0–72 years) and 36486 parents with gastric cancer. Familial risks
for offspring gastric cancer were calculated by using parents,
siblings or parents, and siblings as probands, and by adjusting for
age, period, residential area, and socio-economic status (Table 1).
Only those cancer sites with at least five offspring gastric cancers
(column ‘parent only’) were listed in Table 1. Offspring gastric
cancers were significantly increased when a parent (SIR 1.63) or a
sibling (2.93) was diagnosed with gastric cancer; the risks were
significant even at a 1% level, as indicated by underlined SIRs. The
associations were mainly related to gastric adenocarcinoma. In
order to compare risks for offspring of affected parents and for
siblings, we limited the parental ages to 72 years, and the SIR was
still lower, 1.64 (N¼75, 95% CI 1.29–2.06). The risks were
increased to 1.76 (N¼34, 95% CI 1.22–2.46) for offspring of
affected parents and to 3.99 (N¼6, 95% CI 1.43–8.73) for siblings
if the subjects were diagnosed at ages younger than 50 years.
Conversely, the SIRs were decreased to 1.58 (N¼99, 95% CI 1.29–
1.93) and 2.63 (N¼14, 95% CI 1.43–4.43) if diagnostic ages were
50 years and higher. We further analysed the risk for those
diagnosed after year 1991; the SIRs were 1.79 (N¼126, 95% CI
1.49–2.13) and 2.89 (N¼17, 95% CI 1.68–4.63) in offspring of
affected parents and siblings, respectively.
Offspring gastric cancer was associated with paternal genital
cancers (2.76). Among siblings, gastric cancer was associated with
endometrial (1.65) and urinary bladder cancers (1.67). The risk
was of borderline significance for colorectal cancers (1.37, 95% CI
0.99–1.87) among siblings. When a parent and a sibling were
affected with lung cancer, the SIR for offspring gastric cancer was
significantly increased to 4.19. In the 21 families with gastric and
endometrial cancers among siblings, three siblings were diagnosed
with an endometrial tumour before age 45 years; for parents in
these families, three pancreatic, two gastric, two prostate cancers,
and one colon cancer (age¼40) were observed. For the 24 families
with gastric and urinary bladder cancers among siblings, three
parents were noted with gastric cancer, two parents with
pancreatic cancer, and one parent each with liver, lung, breast,
and prostate cancers, respectively.
Familial cardia and corpus cancers
Because of the different risk factors for cardia and corpus cancers,
we further analyzed the familial risks for the two anatomical sites
based on SNOMED. For cardia cancer (Table 2), significantly
increased SIRs were observed when parents were diagnosed with
all oesophageal cancer (2.94), oesophageal adenocarcinoma (5.67),
and gastric cancer (1.54). When cardia cancer was identified by the
ICD-7 code and diagnosed after age 49 years (covering years
1970–2004, data not shown), a significant association was noted
for nervous system tumours (SIR¼2.42, N¼9, 95% CI 1.10–4.62)
among siblings. Nervous system tumours were further analysed by
histology; the SIR was 4.48 (N¼5, 95% CI 1.41–10.55) and 3.36
(N¼5, 95% CI 1.06–7.91) when siblings presented with glioblas-
toma and any glioma, respectively.
The risk for offspring corpus cancer was significantly increased
to 2.50 and 3.70 when parents were diagnosed with gastric and
corpus cancers, respectively (Table 2). The risk was high when
siblings were presented with gastric cancer (7.28). For discordant
cancer sites, offspring corpus cancer was associated with maternal
breast cancer (1.84) and non-Hodgkin’s lymphoma among sibling
(4.77). An association was also noted for maternal ovarian cancer
(2.02, N¼17, 95% CI 1.17–3.24) when corpus cancer was recorded
by ICD-7 (data not shown).
Familial gastric cancer by histology
We further analyzed the risks for histology specific gastric cancer
in offspring by familial gastric cancer (Table 3). Offspring
unspecified adenocarcinomas showed significantly increased risks
Familial gastric cancer
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swhen parents (1.79) or siblings (2.90) were diagnosed with gastric
cancer. The risks for signet ring cancer were increased when
parents (1.99) or siblings (5.40) presented with gastric cancer. Five
of these signet ring cancers were located in the corpus and two in
cardia; for the others the location was unspecified.
DISCUSSION
The sharp decline in gastric cancer incidence during the past
decades suggests that environmental risk factors play an important
role in its aetiology. A Nordic twin study estimated that 62%
variation in gastric cancer were owing to random environmental
effects, 10% from shared environmental factors, and 28% from
heritable effects (Lichtenstein et al, 2000); however, only the first
figure was significant. Genetic and environmental components for
gastric cancer have also been estimated based on the Swedish
Family-Cancer Database (Czene et al, 2002). The results agreed
with the twin study on the importance of random environmental
effects (71%). Both adult (15%) and childhood (13%) shared
environmental effects were also significant. Only 1% was assigned
for heritable effects. Another piece of evidence on the
Table 1 Risks for gastric cancer in offspring by familial cancers (1961–2004)
Parently only Sibling only Parent and sibling
Familial cancer sites O SIR 95%CI O SIR 95%CI O SIR 95%CI
Upper aerodigestive tract 37 1.09 0.77 1.51 10 1.14 0.54 2.11 0
Oesophagus 14 1.14 0.62 1.92 5 1.95 0.61 4.58 0
Stomach 133 1.63 1.36 1.93 20 2.93 1.79 4.53 2 4.93 0.46 18.13
Adenocarcinoma 116 1.63 1.34 1.95 18 2.90 1.71 4.59 2 6.02 0.57 22.13
Colorectum 182 1.04 0.90 1.21 41 1.37 0.99 1.87 4 1.17 0.30 3.03
Liver 55 1.12 0.85 1.46 4 0.70 0.18 1.82 0
Pancreas 49 1.03 0.76 1.36 9 1.41 0.64 2.69 0
Lung 112 1.10 0.90 1.32 32 1.34 0.92 1.90 6 4.19 1.51 9.19
Breast 150 1.04 0.88 1.22 84 1.10 0.88 1.36 3 0.49 0.09 1.45
Cervix 31 1.06 0.72 1.50 12 1.17 0.60 2.04 0
Endometrium 41 1.08 0.77 1.47 21 1.65 1.02 2.53 1 2.92 0.00 16.75
Ovary 42 1.25 0.90 1.69 20 1.58 0.97 2.45 0
Other female genital 8 1.12 0.48 2.21 0 0
Prostate 207 1.00 0.87 1.15 40 1.11 0.79 1.51 5 0.83 0.26 1.96
Other male genital 7 2.76 1.09 5.72 2 2.11 0.20 7.75 0
Kidney 50 1.04 0.77 1.37 10 1.01 0.48 1.86 0
Urinay bladder 71 1.03 0.80 1.30 24 1.67 1.07 2.49 3 4.98 0.94 14.73
Melanoma 25 0.90 0.58 1.33 26 1.18 0.77 1.74 0
Skin 51 0.91 0.67 1.19 11 1.38 0.69 2.48 0
Nervous system 33 0.92 0.63 1.29 25 1.32 0.85 1.95 0
Thyroid gland 10 0.96 0.46 1.78 9 1.55 0.70 2.96 0
Endocrine glands 12 0.55 0.28 0.97 16 1.55 0.88 2.52 0
Connective tissue 13 1.45 0.77 2.49 6 1.87 0.67 4.10 0
Non-Hodgkin’s lymphoma 49 1.25 0.92 1.65 19 1.34 0.80 2.09 0
Hodgkin’s disease 8 1.23 0.53 2.44 2 0.63 0.06 2.30 0
Myeloma 24 1.02 0.65 1.51 2 0.50 0.05 1.83 0
Leukemia 35 0.85 0.59 1.18 10 1.03 0.49 1.90 0
All 1104 1.04 0.98 1.10 231 1.18 1.04 1.35 205 1.26 1.09 1.44
CI¼confidence interval, O, observed cases. Bold type: 95%CI does not include 1.00; underline type, 99%CI does not include 1.00.
Table 2 Risks for cardia and corpus cancers in offspring by familial cancers (1993–2004)
Parently only Sibling only
Cancer sites O SIR 95%CI O SIR 95%CI
Risk for cardia cancer
Oesophagus 8 2.94 1.26 5.82 1 1.83 0.00 10.52
Adenocarcinoma 3 5.67 1.07 16.80 0
SCC 4 2.17 0.57 5.62 0
Stomach 28 1.54 1.02 2.23 1 0.67 0.00 3.83
Cardia 0 0
Corpus 11 1.20 0.60 2.15 1 2.33 0.00 13.33
Risk for corpus cancer
Oesophagus 0 1 6.27 0.00 35.94
Stomach 12 2.50 1.29 4.38 3 7.28 1.37 21.55
Cardia 0 0
Corpus 9 3.70 1.68 7.06 1 2.33 0.00 13.33
Breast 15 1.84 1.02 3.04 4 0.89 0.23 2.31
Non-Hodgkin’s lymphoma 4 1.80 0.47 4.66 4 4.77 1.24 12.34
CI¼confidence interval, O, observed cases. Bold type: 95%CI does not include 1.00; underline type, 99%CI does not include 1.00.
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senvironmental aetiology of gastric cancer has been the concor-
dance of gastric cancer between spouses (Hemminki and Jiang,
2002a; Amundadottir et al, 2004).
In the present study 35 cancer sites, three groups of probands,
different age groups, and histological types were covered and some
associations were likely to appear by chance. However, only one
SIR was significantly decreased, compared with 10 significantly
increased ones (Table 1), suggesting that chance findings could be
limited. We also calculated the 99% CI to deal with this issue; true
findings could be more possible if they were significant at 1% level.
Additionally, significant associations were examined for biological
plausibility and consistency with other literatures, as discussed
later. Another minor limitation of this study may be the lack of
parental links of a few offspring born in the 1930s, who died before
1991. Such families were excluded from the present study as only
offspring with known parents were considered. Whether this
caused a bias, we calculated the familial risk for offspring
diagnosed after year 1991. The SIRs were essentially unchanged,
suggesting that the present risk estimates were unbiased.
Additionally, data on possible confounding factors, such as diet,
H. pylori infection, and smoking, were unavailable in the Database:
However, the adjustment for socioeconomic status could partly
decrease their effects. Moreover, the low association between
gastric and lung cancer (1.10, Table 1, parental probands)
suggested that smoking was not a confounder of the familial
associations.
In the present study we provided evidence for familial risk
of gastric cancer in first-degree relatives, which may be caused
by heritable and/or shared environmental effects. Significant
associations were observed for offspring of affected parents with
a SIR of 1.63 and for siblings with a SIR of 2.93. However, sibling
risks were not fully comparable with offspring risks in this study,
because of the different age distribution for the offspring and
parental generations in our Database. To compare the risks for
offspring and siblings, the maximal parental age was limited to
72 years; however the SIR for offspring (1.64) was unaltered. The
difference between sibling (3.99) and offspring risks (1.76) was
even higher when the age of onset was limited to lower than 50
years. The high sibling risks may be owing to shared childhood
environmental factors or to a recessive mode of inheritance,
or both. A recent study by Chang et al (2002) showed that
the prevalence of H. pylori infection was 89% when a sibling
had a history of gastric cancer, giving an OR was 5.3; this was
higher than the OR of 2.1 when a parent presented with gastric
cancer. Thus subjects who had a sibling with gastric cancer had a
higher risk of H. pylori infection than subjects with a parental
history of gastric cancer.
H. pylori infections are still common in Sweden. A sample of
1000 Swedes were randomly selected for oesophago-gastro-
duodenoscopy with biopsies and H. pylori serology and one-third
of the subjects had a current infection and a further 10% had signs
of past infection (Storskrubb et al, 2005). The prevalence of
premalignant atrophy and intestinal metaplasia of the corpus was
high among those with current and past infection while
seronegativity excluded such precancerous conditions in the
corpus. Many lines of evidence suggest that H. pylori infection is
related to corpus cancer, rather than to cardia cancer (Siman et al,
1997; Eslick et al, 1999; Kelley and Duggan, 2003; Ye et al, 2004).
Familial risk of corpus cancer was significantly increased when
parents presented with any gastric cancer (2.50). The SIR was even
high for concordant corpus cancers (3.70), suggesting that parents
with corpus cancer were more likely carriers of H. pylori infection.
The risk for corpus cancer among sibling was very high (7.28), in
agreement with the evidence that cross-transmission of H. pylori
infection was more common between siblings than between
parents and offspring (La Vecchia et al, 1995; Goodman and
Correa, 2000). The consistency with the transmission patterns of
H. pylori infection, the high sibling risks, particularly for
concordant corpus cancers, suggest that H. pylori infection was
an important risk factor for the familial risk of corpus cancer in
the present study.
Evidence was provided for an independent familial risk for
cardia cancer in the offspring of affected parents diagnosed with
gastric cancer (1.54). An earlier Swedish case–control study
showed a moderate increase of cardia cancer among subjects with
a familial history of gastric cancer in first-degree relatives.
However, according to the authors, the result could be over-
estimated by reporting bias (Lagergren et al, 2000). A non-
significant excess of cardia cancer was also noted in an US study
among individuals reporting a family history of digestive tract
cancers (Dhillon et al, 2001). In the present study, we observed a
strong familial association between oesophageal adenocarcinoma
and cardia cancer, giving an SIR of 5.67. Infection with H. pylori
could not explain the observed associations, because neither cardia
cancer nor oesophageal adenocarcinoma are related to H. pylori
(Ye et al, 2004). Barrett’s oesophagus is an established risk factor
of both oesophageal adenocarcinoma (OR 43.5) and gastric cardia
cancer (OR 4.4) (Lagergren et al, 1999a). Familial clustering of
Barrett’s oesophagus has been described (Crabb et al, 1985;
Jochem et al, 1992), suggesting that the hereditary components for
Barrett’s oesophagus could be related to both cardia and
oesophageal adenocarcinomas. Other factors, either genetic or
environmental, may be also related to the family aggregations of
cardia cancer (Chow et al, 1998; Zhang et al, 2006).
The histological classification used by the Swedish Cancer
Registry does not specify intestinal and diffuse types of the Lauren
classification and we were thus unable to contribute to the existing
literature (Lehtola, 1978; Palli et al, 1994; Lissowska et al, 1999).
Germ line mutations in the E-cadherin gene have been reported in
Maori kindred with hereditary diffuse type gastric cancer (Guilford
et al, 1998). In the present study, signet ring cancer resembles
diffuse type carcinoma (Hamilton and Aaltonen, 2000), which
showed a significant increase when parents or siblings presented
with gastric cancer.
Gastric cancer is a component in several cancer syndromes, of
which HNPCC, a dominant disease, is the most common (Lynch
and de la Chapelle, 2003; Zhang et al, 2006). The most common
cancer site in HNPCC is the colorectum, which showed a
borderline increase among siblings in the present study. Other
HNPCC-related cancers, endometrial and urinary bladder cancers,
Table 3 Risks for offspring histology specific gastric cancer by familial gastric cancers, (1990–2004)
Histologies O SIR 95%CI O SIR 95%CI
Stomach, all 128 1.76 1.47 2.09 17 2.80 1.63 4.49
Adenocarcinoma 81 1.79 1.42 2.23 11 2.90 1.44 5.20
Carcinoid 5 2.26 0.71 5.32 0
Signet ring cancer 18 1.99 1.18 3.15 4 5.40 1.40 13.95
Gastrointestinal stromal tumours 3 1.23 0.23 3.63 1 5.34 0.00 30.60
CI¼confidence interval, O, observed cases. Bold type: 95%CI does not include 1.00; underline type, 99%CI does not include 1.00.
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sand brain gliomas were in excess but only among siblings, leaving
the association to HNPCC in doubt.
The associations of gastric cancer with lung and bladder cancers
could be related to tobacco smoking, because of the known familial
aggregation of the smoking habit (Fisher, 1958; Tokuhata and
Lilienfeld, 1963; Jonsson et al, 2004; Madden et al, 2004; Lorenzo
Bermejo and Hemminki, 2005). Gastric and lung cancers could
also be linked by H. pylori infection (Gocyk et al, 2000). However,
corpus cancer showed no association with lung cancer. Male
genital cancers associated with all gastric cancer, but the
significance of this observation remains to be established. Human
papilloma virus is a risk factor for male and female genital cancers
(zur Hausen, 1999), and an association of gastric cancer with
female genital cancers has been reported earlier (Goldgar et al,
1994). Corpus cancer associated with non-Hodgkin’s lymphoma.
H. pylori infection is an established cause of gastric lymphomas of
mucosa-associated lymphoid tissue (Wotherspoon et al, 1991;
Parsonnet et al, 1994), but we had no details of the non-Hodgkin’s
lymphoma subtypes. The association of corpus cancer with breast
cancer was in line with a US case–control study (Dhillon et al,
2001). Second corpus cancer has been observed to be in excess
after primary sporadic and familial breast cancers (Ji and
Hemminki, 2006); BRCA1, BRCA2, and E-cadherin gene may be
shared genetic risk factors for the two cancer sites.
In conclusion, the present study showed that familial risks for
concordant gastric cancers were higher for siblings than for
parents and offspring. The excess sibling risk was mainly owing to
corpus cancer for which H. pylori infection may be an important
contributing factor; however, we have no data on H. pylori
infection. Familial clustering for cardia cancer could be indepen-
dent of H. pylori infection, as well as the association of cardia
cancer with oesophageal adenocarcinoma. The associations with
some discordant sites were probably explained by HNPCC and
familial aggregation of smoking but all the discordant associations
need to be confirmed.
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